UPDATED Jun 17, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARES | US$134.03 | -2.1% | 41.9% | US$41.7b | US$146.45 | PE62.1x | E29.7% | 2.8% | Diversified Financials | ||
NVDA | US$130.98 | 8.3% | 199.0% | US$3.2t | US$125.13 | PE75.6x | E22.6% | 0.03% | Semiconductors | ||
CRWD | US$390.43 | 4.2% | 151.7% | US$93.8b | US$400.47 | PE721.7x | E35.4% | n/a | Software | ||
NU | US$11.83 | 0.08% | 56.9% | US$56.2b | US$12.49 | PB8.3x | E37.7% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
PDD | US$148.30 | -0.1% | 85.7% | US$206.9b | US$205.14 | PE18.7x | E23.2% | n/a | Retail | ||
CG | US$39.27 | -3.5% | 25.1% | US$14.1b | US$48.47 | PS6.4x | E23.6% | 3.6% | Diversified Financials | ||
SMCI | US$887.41 | 12.8% | 284.5% | US$49.5b | US$1,032.47 | PE49.5x | E40.2% | n/a | Tech | ||
OWL | US$17.35 | -0.2% | 50.2% | US$24.4b | US$21.17 | PE127x | E88.4% | 4.1% | Diversified Financials | ||
SYM | US$34.12 | -9.5% | -33.4% | US$20.6b | US$56.64 | PS2.3x | E131.1% | n/a | Capital Goods | ||
CELH | US$58.42 | -11.7% | 21.3% | US$14.0b | US$87.55 | PE63.2x | E21.4% | n/a | Food, Beverage & Tobacco | ||
VRT | US$89.55 | -1.9% | 297.3% | US$34.2b | US$102.49 | PE83x | E30.3% | 0.1% | Capital Goods | ||
ZS | US$184.38 | 0.3% | 19.7% | US$27.8b | US$230.30 | PS13.7x | E50.9% | n/a | Software | ||
PTC | US$172.68 | -1.6% | 20.6% | US$20.8b | US$203.05 | PE71.8x | E22.8% | n/a | Software | ||
CHK | US$84.63 | -4.8% | 2.8% | US$11.2b | US$105.56 | PE10.5x | E36.2% | 2.9% | Energy | ||
ALNY | US$157.30 | 2.5% | -22.0% | US$20.3b | US$217.94 | PS9.9x | E63.8% | n/a | Pharmaceuticals & Biotech | ||
RYAN | US$53.33 | -0.7% | 24.1% | US$13.7b | US$58.08 | PE99.8x | E56.6% | 0.8% | Insurance | ||
NTNX | US$54.62 | 1.3% | 87.1% | US$13.3b | US$73.54 | PS6.4x | E82.7% | n/a | Software | ||
ELF | US$195.41 | 7.1% | 87.7% | US$10.8b | US$207.62 | PE85.6x | E21.1% | n/a | Household | ||
SPOT | US$311.22 | 0.7% | 94.5% | US$62.1b | US$342.37 | PS4.2x | E40.5% | n/a | Media | ||
SRPT | US$116.83 | -4.7% | -10.4% | US$11.6b | US$167.08 | PE653.6x | E37.5% | n/a | Pharmaceuticals & Biotech | ||
TER | US$144.74 | 1.2% | 30.3% | US$22.6b | US$128.91 | PE52.6x | E23.8% | 0.3% | Semiconductors | ||
ARM | US$160.29 | 14.6% | n/a | US$164.3b | US$115.12 | PE544.9x | E31.0% | n/a | Semiconductors | ||
TEAM | US$156.62 | -3.4% | -11.9% | US$41.7b | US$240.61 | PS9.8x | E41.3% | n/a | Software |